期刊文献+

PTPMeg2抑制NIH3T3/STAT3CA细胞模型STAT3转录活性的研究

PTPMeg2 inhibits STAT3 transcriptional activity in NIH3T3/STAT3CA cell model
下载PDF
导出
摘要 目的探讨磷酸酶PTPMeg2对NIH3T3/STAT3CA细胞模型的增殖及STAT3转录活性的影响。方法构建STAT3异常突变的细胞模型NIH3T3/STAT3CA,MTT法和裸鼠异体移植瘤实验分别用于观察PTPMeg2对NIH3T3/STAT3CA细胞体外和体内增殖的影响,免疫共沉淀实验用于PTPMeg2与STAT3CA相互作用的研究,双荧光素酶报告基因法用于转录活性的研究。结果 PTPMeg2对NIH3T3/STAT3CA细胞在体外和体内都具有增殖抑制作用,与对照组比较均具有明显的统计学意义。PTPMeg2对NIH3T3/STAT3CA细胞的转录活性具有抑制作用,而PTPMeg2的突变体(PTPMeg2C515S)和ShPTPMeg2则无效。结论 PTPMeg2对NIH3T3/STAT3CA细胞具有增殖抑制作用,其作用机制可能与抑制STAT3的转录活性有关。 Aim To investigate the NIH3T3/STAT3CA cell proliferation ability and the STAT3 transcriptional activity affected by PTPMeg2 . Methods MTT assay and xenograft nude mice model were used to investigate the NIH3 T3/STAT3 CA cell proliferation inhibited by PTPMeg2 in vitro and in vivo. Co-immunoprecipitation assay was used to measure the interaction between PT-PMeg2 and STAT3CA. STAT3 transcriptional activity was measured by dualluciferase assay. Results The NIH3 T3/STAT3 CA cell proliferation ability was signifi-cantly inhibited by PTPMeg2 in vitro and in vivo com-pared with the control group ( P 〈0.05 ) . The tran-scriptional activity was increased by PTPMeg2 , but not the PTPMeg2 mutant (PTPMeg2C515S) and the ShPT-PMeg2 . Conclusion PTPMeg2 plays a role in inhibi-ting the proliferation ability of NIH3 T3/STAT3 CA cells through inhibiting the STAT3 transcriptional activity.
出处 《中国药理学通报》 CAS CSCD 北大核心 2014年第6期843-847,共5页 Chinese Pharmacological Bulletin
基金 黑龙江省自然科学基金资助项目(No D201084)
关键词 PTPMeg2 NIH3T3 STAT3CA 细胞模型 持续激活的 STAT3 增殖 转录活性 PTPMeg2 NIH3T3/STAT3CA cellmodel constitutively activated STAT3 proliferation transcriptional activity
  • 相关文献

参考文献14

  • 1Johnston P A, Grandis J R. STAT3 signaling: anticancer strategies and challenges. Molecular interventions[J]. 2011, 11(1): 18-26.
  • 2Katz L H, Li Y, Chen J S, et al. Targeting TGF-beta signaling in cancer[J]. Exp Opin Therap Targ, 2013, 17(7): 743-60.
  • 3Polakis P. Drugging Wnt signalling in cancer[J]. EMBO J, 2012, 31(12): 2737-46.
  • 4Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors[J]. Oncogene, 2000, 19(21): 2548-56.
  • 5Lee H, Pal S K, Reckamp K, et al. STAT3: a target to enhance antitumor immune response[J]. Curr Top Microbiol Immunol, 2010, 344: 41-59.
  • 6Groner B, Lucks P, Borghouts C. The function of Stat3 in tumor cells and their microenvironment[J]. Semin Cell Dev Biol, 2008, 19(4): 341-50.
  • 7Su F, Ren F, Rong Y, et al. Protein tyrosine phosphatase Meg2 dephosphorylates signal transducer and activator of transcription 3 and suppresses tumor growth in breast cancer[J]. Breast Cancer Res, 2012, 14(2): 13.
  • 8Yuan T, Wang Y, Zhao Z J, Gu H. Protein-tyrosine phosphatase PTPN9 negatively regulates ErbB2 and epidermal growth factor receptor signaling in breast cancer cells[J].J Biol Chem, 2010, 285(20): 14861-70.
  • 9Wang H, Lathia J D, Wu Q, et al. Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth[J]. Stem Cells, 2009, 27(10): 2393-404.
  • 10Caceres-Cortes J R. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490[J]. Anticancer Agents Med Chem, 2008, 8(7): 717-22.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部